AMENDMENT NO. 3 To MANUFACTURING SERVICES AGREEMENT Dated as of 4 May 2018 Between Proteon Therapeutics, Inc. And LONZA LTDManufacturing Services Agreement • August 7th, 2018 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT No. 3 ("Amendment 3") is made effective as of the 4th day of May, 2018 to the Manufacturing Services Agreement, dated 30 June 2015 between Proteon Therapeutics, Inc. (“Proteon” or “Customer”) and Lonza Ltd (“Lonza”), as amended from time to time (the “Agreement”),
